SLC20A1
Sodium-dependent phosphate transporter 1
Also known as: Glvr-1, GLVR1, PiT-1, PiT1, S20A1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WUM9
- Gene
- SLC20A1
- Ensembl
- ENSG00000144136
- Chromosome
- 2
- Canonical length
- 679 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
The protein encoded by this gene is a sodium-phosphate symporter that absorbs phosphate from interstitial fluid for use in cellular functions such as metabolism, signal transduction, and nucleic acid and lipid synthesis. The encoded protein is also a retroviral receptor, causing human cells to be susceptible to infection by gibbon ape leukemia virus, simian sarcoma-associated virus, feline leukemia virus subgroup B, and 10A1 murine leukemia virus.[provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
679 residues, UniProt reviewed canonical sequence.
>Q8WUM9|SLC20A1
1 MATLITSTTA ATAASGPLVD YLWMLILGFI IAFVLAFSVG ANDVANSFGT AVGSGVVTLK
61 QACILASIFE TVGSVLLGAK VSETIRKGLI DVEMYNSTQG LLMAGSVSAM FGSAVWQLVA
121 SFLKLPISGT HCIVGATIGF SLVAKGQEGV KWSELIKIVM SWFVSPLLSG IMSGILFFLV
181 RAFILHKADP VPNGLRALPV FYACTVGINL FSIMYTGAPL LGFDKLPLWG TILISVGCAV
241 FCALIVWFFV CPRMKRKIER EIKCSPSESP LMEKKNSLKE DHEETKLSVG DIENKHPVSE
301 VGPATVPLQA VVEERTVSFK LGDLEEAPER ERLPSVDLKE ETSIDSTVNG AVQLPNGNLV
361 QFSQAVSNQI NSSGHYQYHT VHKDSGLYKE LLHKLHLAKV GDCMGDSGDK PLRRNNSYTS
421 YTMAICGMPL DSFRAKEGEQ KGEEMEKLTW PNADSKKRIR MDSYTSYCNA VSDLHSASEI
481 DMSVKAEMGL GDRKGSNGSL EEWYDQDKPE VSLLFQFLQI LTACFGSFAH GGNDVSNAIG
541 PLVALYLVYD TGDVSSKVAT PIWLLLYGGV GICVGLWVWG RRVIQTMGKD LTPITPSSGF
601 SIELASALTV VIASNIGLPI STTHCKVGSV VSVGWLRSKK AVDWRLFRNI FMAWFVTVPI
661 SGVISAAIMA IFRYVILRMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC20A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 70 nTPM
- colon: 50 nTPM
- retina: 49 nTPM
- liver: 46 nTPM
- urinary bladder: 38 nTPM
- adipose tissue: 35 nTPM
Single-cell type
- ocular epithelial cells: 949 nCPM
- urothelial cells: 798 nCPM
- epicardial cells: 434 nCPM
- prostatic hillock cells: 417 nCPM
- colonocytes: 374 nCPM
- endometrial glandular cells: 369 nCPM
Immune cell
- intermediate monocyte: 60 nTPM
- MAIT T-cell: 60 nTPM
- gdT-cell: 53 nTPM
- NK-cell: 50 nTPM
- plasmacytoid DC: 42 nTPM
- memory CD8 T-cell: 38 nTPM
Brain region
- cerebellum: 58 nTPM
- cerebral cortex: 55 nTPM
- thalamus: 54 nTPM
- pons: 53 nTPM
- choroid plexus: 53 nTPM
- medulla oblongata: 47 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 1.85
- DepMap mean gene effect
- -0.33
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- biomineral tissue development
- cell population proliferation
- monoatomic ion transport
- phosphate ion transmembrane transport
- phosphate-containing compound metabolic process
- positive regulation of canonical NF-kappaB signal transduction
Molecular functions
- phosphate transmembrane transporter activity
- signaling receptor activity
- sodium:phosphate symporter activity
- high-affinity phosphate:sodium symporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC20A1 as an antibody target. Whether an autoantibody or antibody against SLC20A1 could matter depends on whether native SLC20A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC20A1 is annotated at the cell surface, where native SLC20A1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC20A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...